We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
-4%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.26B
AUM Growth
-$362M
Cap. Flow
-$5M
Cap. Flow %
-0.12%
Top 10 Hldgs %
43.71%
Holding
683
New
46
Increased
475
Reduced
93
Closed
17

Top Buys

Rank Stock Value
1
PM icon
Philip Morris
PM
+$38.3M
2
AMZN icon
Amazon
AMZN
+$27.7M
3
PLTR icon
Palantir
PLTR
+$17.5M
4
HIMS icon
Hims & Hers Health
HIMS
+$13.7M
5
YUMC icon
Yum China
YUMC
+$13.2M

Top Sells

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$39.4M
2
NVDA icon
NVIDIA
NVDA
+$30.1M
3
META icon
Meta Platforms (Facebook)
META
+$14.9M
4
BEKE icon
KE Holdings
BEKE
+$14.1M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$11.2M

Sector Composition

Rank Sector Weight
1 Technology 42.45%
2 Consumer Discretionary 16.26%
3 Communication Services 14.17%
4 Healthcare 8.06%
5 Consumer Staples 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INDV icon
451
Indivior Pharmaceuticals
INDV
$4.73B
$33.3K ﹤0.01%
3,490
+628
+22% +$6.6K
CNTA
452
DELISTED
Centessa Pharmaceuticals
CNTA
$32.8K ﹤0.01%
2,283
+411
+22% +$6.72K
WVE icon
453
Wave Life Sciences
WVE
$1.09B
$31.6K ﹤0.01%
3,905
+703
+22% +$7.69K
SPRY icon
454
ARS Pharmaceuticals
SPRY
$509M
$31.3K ﹤0.01%
2,488
+447
+22% +$5.38K
GTY
455
Getty Realty Corp
GTY
$2.11B
$30.9K ﹤0.01%
990
+55
+6% +$1.69K
LTC
456
LTC Properties
LTC
$2.06B
$30.4K ﹤0.01%
857
+67
+8% +$2.33K
DRH icon
457
Diamondrock Hospitality Co
DRH
$2.71B
$30.4K ﹤0.01%
3,932
+166
+4% +$1.4K
IMCR icon
458
Immunocore
IMCR
$1.72B
$30.1K ﹤0.01%
1,014
+183
+22% +$5.49K
GNL icon
459
Global Net Lease
GNL
$1.84B
$29.9K ﹤0.01%
3,713
+153
+4% +$1.15K
ARDX icon
460
Ardelyx
ARDX
$1.22B
$29.8K ﹤0.01%
6,064
+1,091
+22% +$5.86K
OCUL icon
461
Ocular Therapeutix
OCUL
$1.79B
$29.5K ﹤0.01%
4,026
+725
+22% +$5.57K
AUPH icon
462
Aurinia Pharmaceuticals
AUPH
$1.91B
$29.5K ﹤0.01%
3,666
+660
+22% +$5.35K
PCRX icon
463
Pacira BioSciences
PCRX
$1.04B
$29.4K ﹤0.01%
1,182
+212
+22% +$5.08K
IIPR icon
464
Innovative Industrial Properties
IIPR
$1.71B
$29K ﹤0.01%
537
+22
+4% +$1.52K
INVA icon
465
Innoviva
INVA
$1.55B
$29K ﹤0.01%
1,602
+288
+22% +$5.16K
ELME
466
Elme Communities
ELME
$143M
$29K ﹤0.01%
1,667
+80
+5% +$1.29K
ADPT icon
467
Adaptive Biotechnologies
ADPT
$3.59B
$28.1K ﹤0.01%
3,779
+680
+22% +$5.23K
SILA
468
DELISTED
Sila Realty Trust
SILA
$27.8K ﹤0.01%
+1,042
New +$26K
U icon
469
Unity
U
$13.8B
$27.5K ﹤0.01%
+1,403
New +$31.7K
DYN icon
470
Dyne Therapeutics
DYN
$4.7B
$27.2K ﹤0.01%
2,605
+468
+22% +$6.7K
SNDX icon
471
Syndax Pharmaceuticals
SNDX
$1.69B
$26.9K ﹤0.01%
2,186
+394
+22% +$5.56K
VRE
472
DELISTED
Veris Residential
VRE
$26.8K ﹤0.01%
1,584
+77
+5% +$1.24K
UMH
473
UMH Properties
UMH
$1.29B
$26.6K ﹤0.01%
1,420
+64
+5% +$1.17K
GPCR icon
474
Structure Therapeutics
GPCR
$3.41B
$26.4K ﹤0.01%
1,525
+274
+22% +$6.71K
NVAX icon
475
Novavax
NVAX
$1.2B
$26.3K ﹤0.01%
4,101
+738
+22% +$6.1K
17 18
19
20 21

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

GF Fund Management's Q1 2025 Portfolio in Review

As of Q1 2025, GF Fund Management held 683 positions worth $4.26B, down 7.8% from $4.62B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

GF Fund Management's Q1 2025 filing shows 46 new, 475 increased, 93 reduced and 17 closed positions. Its largest new stake was Hims & Hers Health: 368,661 shares worth $10.9M. The largest sale was Pinduoduo, an estimated $39.4M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 45% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • GF Fund Management's largest Q1 2025 buy was Hims & Hers Health: 368,661 shares worth $10.9M.
  • GF Fund Management added most to Philip Morris in Q1 2025, an estimated $38.3M increase.
  • GF Fund Management's biggest Q1 2025 reduction was Pinduoduo, cutting an estimated $39.4M.
  • GF Fund Management fully exited Applied Optoelectronics in Q1 2025, selling an estimated $5.07M.
  • GF Fund Management's ten largest holdings make up 44% of its $4.26B portfolio in Q1 2025.
  • GF Fund Management opened 46 new positions and closed 17 in Q1 2025.
  • GF Fund Management's portfolio value fell 7.8% quarter-over-quarter to $4.26B.

Based on GF Fund Management's 13F filing for Q1 2025, filed 29 Apr 2025.